Novozymes A/S (NSIS-B.CO) Stock Analysis & Winston Score
Novozymes is a Danish company that makes enzymes and microorganisms used across many industries. Its products help detergent makers clean clothes at lower temperatures, food companies produce better bread and beer, and biofuel producers turn crops into energy. It is one of the world's largest industrial enzyme producers, holding a leading share of the global market. Novozymes earns revenue by selling biological solutions to business customers, primarily in household care, food and beverages, bioenergy, and agriculture. The company operates globally with customers in over 100 countries and is headquartered in Copenhagen, Denmark. Its deep expertise in protein engineering and a vast library of proprietary microorganisms give it a strong competitive moat. In 2024, Novozymes merged with Chr. Hansen to form Novonesis, broadening its reach into probiotics and natural colors, though integrating the two businesses and sustaining growth across a wider portfolio remains a key challenge ahead.
Winston Score: 66/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (18/30)
- Growth: Good (13/20)
- Cash Flow: Exceptional (9/10)
- Stability: Exceptional (9/10)
- Valuation: Good (6/10)
- Ownership: Good (10/15)
Key Facts
Price: 456.40 DKK
Market Cap: 212.8B DKK
Sector: Basic Materials
Industry: Chemicals - Specialty
Exchange: NASDAQ Copenhagen


